Stephan S.
- Country
- Germany
- Department
- Department of Gynecology and obstetrics of the University Regensburg
Research Overview
- Comparison of RO7771950 plus combination therapy versus tucatinib plus combination therapy in pretreated HER2-positive locally advanced or metastatic breast cancer
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
- A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER
Data & Insights
Has run more than one trial at 242 of 575 partner sites.
Specializations
Advanced Breast Cancer Treatment
This investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular emphasis on advanced and metastatic cases. Their research encompasses novel therapeutic combinations involving CDK4/6 inhibitors and endocrine therapy.
- Metastatic Breast Cancer Management
- Endocrine Therapy Resistance
- Advanced Treatment Protocols
The investigator explores innovative approaches for patients with PIK3CA mutations and ESR1 mutations in breast cancer.
Early-Stage Breast Cancer
Focus areas include treatment of early breast cancer (EBC) with high risk of recurrence, particularly in node-positive cases. The investigator studies adjuvant therapeutic approaches using targeted combinations.
- Node-Positive Disease Management
- Risk Reduction Strategies
- Adjuvant Treatment Optimization
Research extends to invasive disease-free survival outcomes in early-stage breast cancer patients.
Additional Therapeutic Areas
The investigator's expertise extends to other medical conditions, including chronic venous ulcers (CVU) and epithelial ovarian cancer. Their work includes evaluation of novel therapeutic approaches for treatment-resistant conditions.
- Wound Healing Studies
- PARP Inhibitor Therapy
- Combination Treatment Approaches
Research includes investigation of topical treatments and targeted therapies for various conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.